Hi All,
I was doing my monthly observations on Pharmaust V The Rest of the World in relation to Lymphoma B treatment.
Remembering Global Vet Oncology drug sales were 2020 USD $60 million and expected to be USD $86 million by 2026.
Which Companies are at the forefront.
1. Elanco with Aratana. Intravenous
2. Zoetis with Palladia. USD $6 per tablet
3. Nippon Zenyaku with a CD 20 antibody on trial Phase 2b.
4. Vet DC with Tanovea. ( ? Side effects)
5. Advavet with Doxorubicin ( Chemo drug ? Side effects )
That leaves us with one big Pharma Boehringer sitting by itself with a discontinued Lymphoma B drug that didn't complete a Phase 3 trial and a small Company called Rhizen Pharmaceutical that are specialising in T cell Lymphoma.
Of course on the PAA payroll is Dr Kim Agnew who was head of R & D Pacific Region Boehringer ( though it was called Merial ) back then.
RA has let it out we have a new partner.
Odds are shortening ?
Come May 2022 , I anticipate a big smile on our faces.
Everyone on this forum knows the Science is excellent.
- Forums
- ASX - By Stock
- PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III
Hi All,I was doing my monthly observations on Pharmaust V The...
-
- There are more pages in this discussion • 1,376 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
|
|||||
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.55M |
Open | High | Low | Value | Volume |
19.5¢ | 19.5¢ | 18.5¢ | $330.4K | 1.741M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4071 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 24580 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4071 | 0.190 |
12 | 453603 | 0.185 |
14 | 471449 | 0.180 |
8 | 743200 | 0.175 |
4 | 115882 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 346149 | 3 |
0.205 | 55141 | 4 |
0.210 | 300000 | 2 |
0.215 | 459058 | 6 |
0.220 | 239679 | 2 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online